Stephen Friend
#66,943
Most Influential Person Now
American scientist
Stephen Friend's AcademicInfluence.com Rankings
Stephen Friendbiology Degrees
Biology
#4138
World Rank
#6218
Historical Rank
#1598
USA Rank
Genetics
#991
World Rank
#1088
Historical Rank
#264
USA Rank
Stephen Friendphilosophy Degrees
Philosophy
#4344
World Rank
#6825
Historical Rank
#1272
USA Rank
Logic
#5051
World Rank
#6410
Historical Rank
#857
USA Rank
Download Badge
Biology Philosophy
Why Is Stephen Friend Influential?
(Suggest an Edit or Addition)According to Wikipedia, Stephen H. Friend is co-founder and director of Sage Bionetworks. Formerly Senior Vice-president at Merck & Co. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996. Much of his research has focused on cancer.
Stephen Friend's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gene expression profiling predicts clinical outcome of breast cancer (2002) (9734)
- Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. (1999) (4002)
- A gene-expression signature as a predictor of survival in breast cancer. (2002) (3325)
- The Consensus Molecular Subtypes of Colorectal Cancer (2015) (3194)
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma (1986) (2880)
- Functional Discovery via a Compendium of Expression Profiles (2000) (2725)
- Genome-wide methylation profiles reveal quantitative views of human aging rates. (2013) (2254)
- Genetics of gene expression surveyed in maize, mouse and man (2003) (1549)
- Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product (1988) (1451)
- Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer (2001) (1335)
- An Information-Intensive Approach to the Molecular Pharmacology of Cancer (1997) (1134)
- Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. (1997) (944)
- Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. (2000) (930)
- Integrating genetic approaches into the discovery of anticancer drugs. (1997) (728)
- Predictive, personalized, preventive, participatory (P4) cancer medicine (2011) (637)
- Gene expression changes associated with progression and response in chronic myeloid leukemia. (2006) (570)
- Overexpression of a kinase‐inactive ATR protein causes sensitivity to DNA‐damaging agents and defects in cell cycle checkpoints (1998) (569)
- Widespread aneuploidy revealed by DNA microarray expression profiling (2000) (501)
- Drug target validation and identification of secondary drug target effects using DNA microarrays (1998) (470)
- The mPower study, Parkinson disease mobile data collected using ResearchKit (2016) (432)
- Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. (1987) (411)
- Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. (1996) (400)
- Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. (1992) (373)
- Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. (1995) (345)
- Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein (1990) (305)
- A network view of disease and compound screening (2009) (270)
- Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases (2016) (266)
- A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. (2005) (263)
- Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection (2015) (261)
- Leveraging models of cell regulation and GWAS data in integrative network-based association studies (2012) (249)
- Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. (1989) (241)
- Screening patients for heterozygous p53 mutations using a functional assay in yeast (1993) (233)
- Cancer BiomarkersAn Invitation to the Table (2006) (207)
- Inferring causal molecular networks: empirical assessment through a community-based effort (2016) (205)
- Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes (2017) (204)
- Pleuropulmonary blastoma: a marker for familial disease. (1996) (203)
- Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. (1994) (199)
- Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. (1991) (198)
- Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome. (1995) (196)
- Oncogenes and tumor-suppressing genes. (1988) (195)
- Genetic selection of peptide inhibitors of biological pathways. (1999) (194)
- Expression profiling predicts outcome in breast cancer (2002) (183)
- Toxicogenomics and drug discovery: will new technologies help us produce better drugs? (2002) (181)
- Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP53 Disruptions (2006) (180)
- Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae. (2000) (180)
- Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening Mammograms (2020) (168)
- Systematic Assessment of Analytical Methods for Drug Sensitivity Prediction from Cancer Cell Line Data (2013) (166)
- p53: a glimpse at the puppet behind the shadow play. (1994) (154)
- Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling (2013) (148)
- Crowdsourcing biomedical research: leveraging communities as innovation engines (2016) (135)
- Characterization of human Gadd45, a p53-regulated protein. (1994) (125)
- The Use of Smartphones for Health Research. (2017) (122)
- Recommendations on predictive testing for germ line p53 mutations among cancer-prone individuals. (1992) (121)
- Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. (2004) (121)
- How molecular profiling could revolutionize drug discovery (2005) (120)
- Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. (2017) (114)
- Systematic Analysis of Challenge-Driven Improvements in Molecular Prognostic Models for Breast Cancer (2013) (113)
- Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors. (2015) (109)
- The Development of Muscular Christianity in Victorian Britain and Beyond (2005) (108)
- Mining the NCI Anticancer Drug Discovery Databases: Genetic Function Approximation for the QSAR Study of Anticancer Ellipticine Analogues (1998) (107)
- Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas (2013) (106)
- Prediction of human population responses to toxic compounds by a collaborative competition (2015) (101)
- High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide. (1998) (95)
- Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae (1998) (94)
- Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. (1992) (93)
- Cancer risks from germline p53 mutations. (1992) (90)
- Electrostatic stabilization in myoglobin. pH dependence of summed electrostatic contributions. (1979) (88)
- Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. (1995) (81)
- Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activity. (1998) (81)
- Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. (1996) (81)
- Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease (2016) (78)
- Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis (2016) (74)
- A functional screen for germ line p53 mutations based on transcriptional activation. (1992) (73)
- Microarrays—the 21st century divining rod? (2001) (71)
- A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets. (2003) (70)
- Potential of the Synthetic Lethality Principle (2013) (69)
- An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. (1996) (66)
- Predictive Genes in Adjacent Normal Tissue Are Preferentially Altered by sCNV during Tumorigenesis in Liver Cancer and May Rate Limiting (2011) (66)
- Leveraging Crowdsourcing to Facilitate the Discovery of New Medicines (2011) (61)
- Embracing Complexity, Inching Closer to Reality (2005) (60)
- Developing predictive molecular maps of human disease through community-based modeling (2011) (60)
- Discrete charge calculations of potentiometric titrations for globular proteins: sperm whale myoglobin, hemoglobin alpha chain, cytochrome c. (1978) (59)
- Proton nuclear magnetic resonance study of histidine ionizations in myoglobins of various species. Comparison of observed and computed pK values. (1978) (58)
- First, design for data sharing (2016) (57)
- The importance of p53 gene alterations in human cancer: is there more than circumstantial evidence? (1993) (56)
- Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype. (1994) (53)
- Opening Up to Precompetitive Collaboration (2010) (53)
- Colorectal Cancer Subtyping Consortium (CRCSC) identification of a consensus of molecular subtypes. (2014) (51)
- Structure and expression of the Xenopus retinoblastoma gene. (1992) (48)
- Small Interfering RNA Screens Reveal Enhanced Cisplatin Cytotoxicity in Tumor Cells Having both BRCA Network and TP 53 Disruptions ‡ (2006) (47)
- Detecting the impact of subject characteristics on machine learning-based diagnostic applications (2019) (47)
- Global optimization of somatic variant identification in cancer genomes with a global community challenge (2014) (43)
- Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection (2018) (42)
- Clues from the resilient (2014) (39)
- Challenges in identifying cancer genes by analysis of exome sequencing data (2016) (38)
- Modeling RAS Phenotype in Colorectal Cancer Uncovers Novel Molecular Traits of RAS Dependency and Improves Prediction of Response to Targeted Agents in Patients (2013) (38)
- Breast cancer information on the web (1995) (37)
- Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology (2013) (36)
- The NIH BD2K center for big data in translational genomics (2015) (36)
- Electrostatic stabilization in myoglobin. Interactive free energies between individual sites. (1979) (36)
- Genetic sequences that predispose to retinoblastoma and osteosarcoma. (1986) (35)
- How DNA microarrays and expression profiling will affect clinical practice (1999) (35)
- Metcalfe's law and the biology information commons (2013) (35)
- Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes (1997) (34)
- The magic of microarrays. (2002) (34)
- Smartphones as new tools in the management and understanding of Parkinson’s disease (2016) (34)
- Analysis of electrostatic interactions and their relationship to conformation and stability of bovine pancreatic trypsin inhibitor. (1982) (33)
- An accelerated pathway for targeted cancer therapies (2011) (32)
- A Crowdsourcing Approach to Developing and Assessing Prediction Algorithms for AML Prognosis (2016) (32)
- The Stream Algorithm: Computationally Efficient Ridge-Regression via Bayesian Model Averaging, and Applications to Pharmacogenomic Prediction of Cancer Cell Line Sensitivity (2013) (31)
- Emerging uses for genomic information in drug discovery. (1998) (31)
- Personalized Hypothesis Tests for Detecting Medication Response in Parkinson Disease Patients Using iPhone Sensor Data (2016) (29)
- The Need for Precompetitive Integrative Bionetwork Disease Model Building (2010) (27)
- Unlocking stress and forecasting its consequences with digital technology (2019) (27)
- The Precompetitive Space: Time to Move the Yardsticks (2011) (26)
- Genetic models for studying cancer susceptibility. (1993) (26)
- Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease (2015) (26)
- Cheap DNA arrays—it's not all smoke and mirrors (1999) (25)
- Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge (2013) (24)
- Electrostatic effects in hemoglobin: electrostatic energy associated with allosteric transition and effector binding. (1981) (24)
- Secondary breast cancer in patients presenting with osteosarcoma: possible involvement of germline p53 mutations. (1994) (23)
- Contributions of individual amino acid residues to the structural stability of cetacean myoglobins. (1983) (23)
- Charge-site communication in proteins: electrostatic heme linkage of azide binding by sperm whale myoglobin. (1980) (22)
- Breast cancer susceptibility testing: realities in the post–genomic era (1996) (22)
- Protein-protein interactions: nature of the electrostatic stabilization of deoxyhemoglobin tetramer formation. (1981) (22)
- Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. (1997) (20)
- Prolonged survival of a child with metastatic retinoblastoma. (1987) (20)
- Erratum: Germ-line mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms (New England Journal of Medicine (May 14, 1992)) (1997) (20)
- POINT: Are we prepared for the future doctor visit? (2011) (17)
- A functional assay for heterozygous mutations in the GTPase activating protein related domain of the neurofibromatosis type 1 gene. (1995) (16)
- App-enabled trial participation: Tectonic shift or tepid rumble? (2015) (16)
- Laboratory–clinical interface (1993) (16)
- Electrostatic stabilization in sperm whale and harbor seal myoglobins. Identification of groups primarily responsible for changes in anchoring of the A helix. (1980) (15)
- Impact of centralization on aCGH-based genomic profiles for precision medicine in oncology. (2015) (15)
- The role of tumour suppressor genes in familial cancer. (1992) (13)
- A systems genetics study of swine illustrates mechanisms underlying human phenotypic traits (2015) (13)
- The inconvenience of data of convenience: computational research beyond post-mortem analyses (2017) (12)
- The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer. (2015) (11)
- Integrative Network-based Association Studies: Leveraging cell regulatory models in the post-GWAS era (2011) (11)
- The cancer predisposition revolution (2016) (10)
- Expression profiling predicts poor outcome of disease in young breast cancer patients (2001) (10)
- Correction: a Li-Fraumeni syndrome p53 mutation. (1993) (9)
- Screening for cancer susceptibility in children. (1994) (8)
- Correction: A Li-Fraumeni Syndrome p53 Mutation (1993) (8)
- Towards personalized causal inference of medication response in mobile health: an instrumental variable approach for randomized trials with imperfect compliance (2016) (7)
- Using Patient-Initiated Study Participation in the Development of Evidence for Personalized Cancer Therapy (2011) (6)
- Valuing Health Care: Improving Productivity and Quality (2012) (6)
- Learning Disease vs Participant Signatures: a permutation test approach to detect identity confounding in machine learning diagnostic applications (2017) (6)
- Anti-oncogenes and the negative regulation of cell growth. (1988) (5)
- UICC study group on basic and clinical cancer research: Multigene effects influencing each other (1996) (5)
- O-0025COLORECTAL CANCER SUBTYPING CONSORTIUM (CRCSC) IDENTIFIES CONSENSUS OF MOLECULAR SUBTYPES (2014) (5)
- Accelerating drug discovery: Open source cancer cell biology? (2006) (5)
- Disrupting the power balance between doctors and patients in the digital era. (2021) (4)
- Cancer risks from germ line tumor suppressor gene mutations. (1991) (4)
- Cancer: genetic and nutritional aspects. (1990) (4)
- The Carbamate Reaction with Proteins: Observation by 13C-NMR and Evaluation of Structural Consequences (1980) (4)
- A simple recipe for drug interaction networks earns its stars (2006) (4)
- Overcoming complexities in genetic screening for cancer susceptibility. (1994) (4)
- Emerging approaches in molecular profiling affecting oncology drug discovery. (2005) (3)
- Identification of cancer-prone individuals: p53 and family cancer syndromes. (1992) (3)
- Electrostatic Interactions Associated with Effector Binding to Hemoglobin (1982) (3)
- Something wiki this way comes. Interview by Bryn Nelson. (2009) (3)
- Effect of self-managed lifestyle treatment on glycemic control in patients with type 2 diabetes (2022) (3)
- An Alternative to the Light Touch Digital Health Remote Study: The Stress and Recovery in Frontline COVID-19 Health Care Workers Study (2021) (3)
- Stress-related consequences of the coronavirus disease 2019 pandemic on symptoms of Crohn’s disease (2021) (3)
- Developmental genetics and childhood cancer. AACR special conference in cancer research. (1991) (2)
- Abstract 2409: A model of RAS pathway in colorectal cancer elucidates molecular traits and drug sensitivity: an integrated analysis of gene expression from human tumors, mouse xenografts and the Cancer Cell Line Encyclopedia (CCLE). (2013) (2)
- Thirteenth annual pezcoller symposium: focusing analytical tools on complexity in cancer. (2002) (2)
- INTEGRATIVE NETWORK ANALYSIS OF MULTIPLE ALZHEIMER'S DISEASE RNASEQ STUDIES FROM THE ACCELERATING MEDICINE PARTNERSHIP-ALZHEIMER'S DISEASE CONSORTIUM (2016) (2)
- Alfred Knudson: The importance of a visionary who enables scientists (2003) (2)
- Erratum: Prediction of human population responses to toxic compounds by a collaborative competition (2015) (2)
- A sense of belonging : religion and identity in Yorkshire and Humber fishing communities, c.1815-1914. (2010) (2)
- Gene Expression Changes at Recurrence After Radiation in Patients With High-Grade Gliomas Predicts Survival (2013) (1)
- Biomedical technology and the clinic of the future. (2011) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- Book Review: The Sacramental Sea: A Spiritual Voyage through Christian History (2020) (1)
- Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer (2015) (1)
- Sibling rivalry, arrested development and chromosomal mayhem (1998) (1)
- Correction for Bernards et al., Structure and Expression of the Murine Retinoblastoma Gene and Characterization of its Encoded Protein, PNAS 1989 86:6474-6478 (2006) (1)
- Artificial neural networks were used to decipher gene-expression signatures collected with DNA microarrays and to classify cancers into specific categories. Will this technology lead to better diagnostic tools and new therapeutic targets? (pages 673-679) Microarrays—the 21st century divining rod? (2001) (0)
- CANCER : THE INTERFACE BETWEEN BASIC AND APPLIED RESEARCH American Association for Cancer Research Conference Baltimore , WA ; November 5-8 , 1995 (2007) (0)
- Abstract 772: The molecular landscape of dermal neurofibromatosis (2016) (0)
- Abstract LB-248: Towards a global picture of breast cancer: transcriptional networks, pathways, regulators, and validation (2010) (0)
- Abstract 1210: Periostin expression in glioma correlates with genes related to mesenchymal transition and survival. (2013) (0)
- Abstract IA-10: Examining the scale and scope of tools and programs to navigate in translational oncology space: Lessons learned (2009) (0)
- Abstract 88: Systems Biology Approaches to Exploring Molecular Mechanisms Underlying Blood Pressure Regulation (2012) (0)
- Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC). (2016) (0)
- Human DNA for the detection of Retinoblastoma (1987) (0)
- Open challenges: Real time data, novel ways to understand dementia (2015) (0)
- Compositions et methodes d'evaluation des niveaux d'expression des exons (2001) (0)
- L6.4 The Marriage of ‘Translational Medicine’ to ‘Big Data’: Key Opportunities to Change how we do Science (2012) (0)
- Building a Next Generation Model for Biomedical Research: Validation of Health Sensors using Online Community Registries and Collaborative Data Interpretation (2017) (0)
- Q&A: Stephen Friend on a bioinformation commons. (2012) (0)
- Advances in Brief Equal Transcription of Wild-Type and Mutant p 53 Using Bicistronic Vectors Results in the Wild-Type Phenotype 1 (2007) (0)
- Multigene effects influencing each other (1997) (0)
- Ecran letal synthetique par interference arn (2004) (0)
- In Focus social interactomes for enabling Research Communities (2014) (0)
- 19 How Do We Study Network Perturbations in Clinical Specimens? How do we Select “Drivers” of Malignancies? (2011) (0)
- Human retinoblastoma polypeptide, its antibody its composition and its detection (1996) (0)
- Prognostication using molecular (mol) markers and clinicopathological (clpath) features in high-risk stage II/III colon cancer (CC). (2016) (0)
- Establishing the research priorities for major trauma in the United Kingdom: A Delphi study of nurses and allied health professionals. (2023) (0)
- Book Review: A Naval History of the Peloponnesian War: Ships, Men and Money in the War at Sea, 431–404 BC (2018) (0)
- The North Sea Liquor Trade, c. 1850–1893 (2003) (0)
- More than 3.700 guests from more than 80 countries have attended the Falling Walls Conferences in the past six years, among them over 400 young academics who received free access by scholarships. (2015) (0)
- The Retinoblastoma Gene: Its Role in Retinal Tumors and Non-Ocular Tumors (1991) (0)
- A Sense of Belonging (2023) (0)
- The State of the Video Game Industry and Potential Implications of Current Business Practices (2018) (0)
- Fishing for Souls (2018) (0)
- US-EU Scientific Research Collaborations: Sage Bionetworks’ Experience Navigating the Complex Regulatory Landscape (2013) (0)
- Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen (2019) (0)
- Correction: An Alternative to the Light Touch Digital Health Remote Study: The Stress and Recovery in Frontline COVID-19 Health Care Workers Study (2022) (0)
- Critic at Large: Crowdsourcing Drug Discovery (2010) (0)
- The Post-Roe Political Landscape Demands a Morality of Caution for Women’s Health (2022) (0)
- Device-based assessment through a mobile application in the Luxembourg Parkinson Cohort (2017) (0)
- Abstract 5323: Integrated computational cell-line modeling of drug sensitivity and high-throughput siRNA screening reveals novel molecular biomarkers for conventional chemotherapy (2014) (0)
- Building a Research Ecosystem upon the Early Success of ResearchKit (2016) (0)
- Abstract 359: An age-related 99-gene signature from glioblastoma implicates differences in survival related to RAS activation (2014) (0)
- Strengths and weaknesses in the current applications of expression profiling (1999) (0)
- Structure andexpression ofthemurineretinoblastoma geneand characterization ofitsencoded protein (recessive oncogene/DNA sequence analysis/leucine zipper) (1989) (0)
- Abstract A130: Joint cell-line (CCLE, Sanger) and patient (TCGA) modeling of drug sensitivity reveals novel molecular biomarkers for targeted therapy and conventional chemotherapy. (2013) (0)
- Something in Common (2010) (0)
- An alternative to the ‘light touch’ digital health remote study: The Stress and Recovery in Frontline COVID-19 Healthcare Workers Study (Preprint) (2021) (0)
- The digital redesign of mental health: leveraging connected digital technologies for agency-driven patient-focused care (2022) (0)
- Cognitive assessments using mobile technologies: moving beyond the inflection point (2015) (0)
- Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis (2016) (0)
- Abstract 4938: A global landscape of transcriptional interactions and regulations in lung cancer (2012) (0)
- DREAM Community. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial (2016) (0)
- Abstract IA15: Predicting drug sensitivity from cancer cell lines (2012) (0)
- Abstract 603: Consensus molecular subtyping through a community of experts advances unsupervised gene expression-based disease classification and facilitates clinical translation (2015) (0)
- COMBING EVIDENCE ACROSS MULTIPLE COHORTS FOR SYSTEMS-BASED TARGET DISCOVERY: THE AMP-AD KNOWLEDGE PORTAL (2016) (0)
- Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection (2018) (0)
- Joint cell-line and patient modeling of drug sensitivity reveals novel molecular biomarkers for targeted and conventional chemotherapy. (2014) (0)
- Abstract PR8: From prediction to prognosis and therapeutics: The power of breast cancer transcriptional networks (2011) (0)
- The emerging translational oncology toolkit (2008) (0)
- Combining accurate tumour genome simulation with crowd-sourcing to benchmark somatic variant detection (2015) (0)
- AMERICAN ASSOCIATION FOR CANCER RESEARCH SCIENTIFIC CONFERENCES (1995) (0)
- Human DNA for diagnosis of retinoblastoma. (1987) (0)
- Social interactomes for enabling research communities. (2014) (0)
- Human DNA for the diagnosis of glioma retinae. (1987) (0)
- Multigene effects influencing each other. International Union Against Cancer Study Group on Basic and Clinical Cancer Research. (1997) (0)
- An accelerated pathway for targeted cancer therapies A well-defined pathway for the accelerated development and approval of targeted cancer therapies and companion diagnostics would reduce uncertainty, improve efficiency in development and provide an effective incentive for developers. (2011) (0)
This paper list is powered by the following services:
Other Resources About Stephen Friend
What Schools Are Affiliated With Stephen Friend?
Stephen Friend is affiliated with the following schools:
